TY - STD TI - Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published online ahead of print, 2020 Mar 11] [published correction appears in Lancet. 2020 Mar 12;:]. Lancet. 2020;S0140-6736(20)30566-3. ID - ref1 ER - TY - STD TI - Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application [published online ahead of print, 2020 Mar 10]. Ann Intern Med. 2020;https://doi.org/10.7326/M20-0504. ID - ref2 ER - TY - STD TI - Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]. JAMA Intern Med. 2020;https://doi.org/10.1001/jamainternmed.2020.0994. ID - ref3 ER - TY - STD TI - Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. ID - ref4 ER - TY - STD TI - Hajifathalian K, Kumar S, Newberry C, et al. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City [published online ahead of print, 2020 May 29]. Obesity (Silver Spring). 2020;https://doi.org/10.1002/oby.22923. ID - ref5 ER - TY - STD TI - Kalligeros M, Shehadeh F, Mylona EK, et al. Association of Obesity with Disease Severity among Patients with COVID-19 [published online ahead of print, 2020 Apr 30]. Obesity (Silver Spring). 2020;https://doi.org/10.1002/oby.22859. ID - ref6 ER - TY - STD TI - Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York [published online ahead of print, 2020 May 16]. Metabolism. 2020;108:154262. ID - ref7 ER - TY - STD TI - Goren A, Vano-Galvan S, Wambier CG, et al. A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity [published online ahead of print, 2020 Apr 16]. J Cosmet Dermatol. 2020;https://doi.org/10.1111/jocd.13443. ID - ref8 ER - TY - STD TI - Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy [published online ahead of print, 2020 Apr 1]. Dermatol Ther. 2020;e13365. ID - ref9 ER - TY - STD TI - Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV [published online ahead of print, 2020 Feb 17]. Biochem Biophys Res Commun. 2020;S0006-291X(20)30339-9. ID - ref10 ER - TY - JOUR AU - Hoffmann, M. AU - Kleine-Wever, H. AU - Kruger, N. AU - Muller, M. AU - Drotsten, C. AU - Pholhlmann, S. PY - 2020 DA - 2020// TI - The novel coronavirus 2019 (2019-nCoV) uses the SARS coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry in target cells JO - Cell VL - 181 UR - https://doi.org/10.1016/j.cell.2020.02.052 DO - 10.1016/j.cell.2020.02.052 ID - Hoffmann2020 ER - TY - JOUR AU - Kuba, K. AU - Imai, Y. AU - Rao, S. AU - Gao, H. AU - Guo, F. AU - Guan, B. AU - Huan, Y. AU - Yang, P. AU - Zhang, Y. AU - Deng, W. AU - Bao, L. AU - Zhang, B. AU - Liu, G. AU - Wang, Z. AU - Chappell, M. C. AU - Liu, Y. AU - Zheng, D. AU - Leibbrandt, A. AU - Wada, T. AU - Slutsky, A. S. AU - Liu, D. AU - Qin, C. AU - Jiang, C. AU - Penninger, J. M. PY - 2005 DA - 2005// TI - A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury JO - Nature Med VL - 11 UR - https://doi.org/10.1038/nm1267 DO - 10.1038/nm1267 ID - Kuba2005 ER - TY - JOUR AU - Xu, H. AU - Zhong, L. AU - Deng, J. AU - Peng, J. AU - Dan, H. AU - Zeng, X. AU - Li, T. AU - Chen, Q. PY - 2020 DA - 2020// TI - High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa JO - Int J Oral Science VL - 12 UR - https://doi.org/10.1038/s41368-020-0074-x DO - 10.1038/s41368-020-0074-x ID - Xu2020 ER - TY - STD TI - Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 2020;19:410–417. Published 2020 Mar 18. ID - ref14 ER - TY - JOUR AU - Yan, T. AU - Xiao, R. AU - Lin, G. PY - 2020 DA - 2020// TI - Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword? JO - FASEB J. VL - 34 UR - https://doi.org/10.1096/fj.202000782 DO - 10.1096/fj.202000782 ID - Yan2020 ER - TY - JOUR AU - Zou, Z. AU - Yan, Y. AU - Shu, Y. PY - 2014 DA - 2014// TI - Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4594 DO - 10.1038/ncomms4594 ID - Zou2014 ER - TY - JOUR AU - Gu, H. AU - Xie, Z. AU - Li, T. PY - 2016 DA - 2016// TI - Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep19840 DO - 10.1038/srep19840 ID - Gu2016 ER - TY - JOUR AU - Khan, A. AU - Benthin, C. AU - Zeno, B. PY - 2017 DA - 2017// TI - A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome JO - Crit Care VL - 21 UR - https://doi.org/10.1186/s13054-017-1823-x DO - 10.1186/s13054-017-1823-x ID - Khan2017 ER - TY - JOUR AU - Batlle, D. AU - Wysocki, S. K. PY - 2020 DA - 2020// TI - Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? JO - Clinical Science VL - 134 UR - https://doi.org/10.1042/CS20200163 DO - 10.1042/CS20200163 ID - Batlle2020 ER - TY - STD TI - Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020 (Epub ahead of print). ID - ref20 ER - TY - JOUR AU - Baig, A. M. AU - Khaleeq, A. AU - Ali, U. AU - Syeda, H. PY - 2020 DA - 2020// TI - Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms JO - ACS Chem Neurosci. VL - 11 UR - https://doi.org/10.1021/acschemneuro.0c00122 DO - 10.1021/acschemneuro.0c00122 ID - Baig2020 ER - TY - STD TI - Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients [published online ahead of print, 2020 Feb 27]. J Med Virol. 2020;https://doi.org/10.1002/jmv.25728. ID - ref22 ER - TY - STD TI - Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824. doi:https://doi.org/10.1016/j.jns.2020.116824. ID - ref23 ER - TY - STD TI - Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models [published online ahead of print, 2020 Apr 25]. Eur J Neurol. 2020;https://doi.org/10.1111/ene.14277. ID - ref24 ER - TY - STD TI - Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection [published online ahead of print, 2020 Apr 15]. N Engl J Med. 2020;NEJMc2008597. ID - ref25 ER - TY - STD TI - Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection [published online ahead of print, 2020 Apr 2]. Gut. 2020;gutjnl-2020-321013. ID - ref26 ER - TY - STD TI - Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis [published online ahead of print, 2020 Apr 3]. Gastroenterology. 2020;S0016-5085(20)30448-0. ID - ref27 ER - TY - STD TI - Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2 [published online ahead of print, 2020 Mar 3]. Gastroenterology. 2020;. doi:https://doi.org/10.1053/j.gastro.2020.02.055. ID - ref28 ER - TY - STD TI - Recalcati S. Cutaneous manifestations in COVID-19: a first perspective [published online ahead of print, 2020 Mar 26]. J Eur Acad Dermatol Venereol. 2020;https://doi.org/10.1111/jdv.16387. ID - ref29 ER - TY - STD TI - Mungmungpuntipantip R, Wiwanitkit V. COVID-19 and Cutaneous manifestations [published online ahead of print, 2020 Apr 15]. J Eur Acad Dermatol Venereol. 2020;https://doi.org/10.1111/jdv.16483. ID - ref30 ER - TY - STD TI - Zhu H, Rhee JW, Cheng P, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22(5):32. Published 2020 Apr 21. ID - ref31 ER - TY - STD TI - Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient [published online ahead of print, 2020 Apr 13]. Eur Heart J. 2020;ehaa288. ID - ref32 ER - TY - STD TI - Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19 [published online ahead of print, 2020 Apr 9]. J Cardiovasc Electrophysiol. 2020;https://doi.org/10.1111/jce.14479. ID - ref33 ER - TY - STD TI - Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights [published online ahead of print, 2020 Apr 10]. Infection. 2020;https://doi.org/10.1007/s15010-020-01424-5. ID - ref34 ER - TY - STD TI - Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections [published online ahead of print, 2020 Mar 14]. Liver Int. 2020;https://doi.org/10.1111/liv.14435. ID - ref35 ER - TY - STD TI - Lee IC, Huo TI, Huang YH. Gastrointestinal and Liver Manifestations in Patients with COVID-19 [published online ahead of print, 2020 Apr 1]. J Chin Med Assoc. 2020;https://doi.org/10.1097/JCMA.0000000000000319. ID - ref36 ER - TY - STD TI - Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?. Arab J Gastroenterol. 2020;21(1):3–8. doi:https://doi.org/10.1016/j.ajg.2020.03.002. ID - ref37 ER - TY - STD TI - Fanelli V, Fiorentino M, Cantaluppi V, et al. Acute kidney injury in SARS-CoV-2 infected patients. Crit Care. 2020;24(1):155. Published 2020 Apr 16. ID - ref38 ER - TY - STD TI - Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67(2):698–705. ID - ref39 ER - TY - STD TI - Abobaker A, Raba AA. Does COVID-19 affect male fertility? [published online ahead of print, 2020 Apr 21]. World J Urol. 2020;https://doi.org/10.1007/s00345-020-03208-w. ID - ref40 ER - TY - STD TI - Cardona Maya WD, Du Plessis SS, Velilla PA. SARS-CoV-2 and the Testis: similarity to other viruses and routes of infection [published online ahead of print, 2020 Apr 17]. Reprod Biomed Online. 2020;doi:https://doi.org/10.1016/j.rbmo.2020.04.009. ID - ref41 ER - TY - STD TI - Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [published online ahead of print, 2020 Apr 10]. Thromb Res. 2020;S0049-3848(20)30120-1. ID - ref42 ER - TY - STD TI - Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients [published online ahead of print, 2020 Apr 22]. J Thromb Haemost. 2020;https://doi.org/10.1111/jth.14869. ID - ref43 ER - TY - STD TI - Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis [published online ahead of print, 2020 Apr 17]. J Thromb Haemost. 2020;https://doi.org/10.1111/jth.14850. ID - ref44 ER - TY - STD TI - Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia [published online ahead of print, 2020 Apr 9]. J Thromb Haemost. 2020;https://doi.org/10.1111/jth.14830. ID - ref45 ER - TY - STD TI - Rotzinger DC, Beigelman-Aubry C, von Garnier C, Qanadli SD. Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography [published online ahead of print, 2020 Apr 11]. Thromb Res. 2020;190:58–59. doi:https://doi.org/10.1016/j.thromres.2020.04.011. ID - ref46 ER - TY - STD TI - Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past [published online ahead of print, 2020 Apr 9]. J Clin Virol. 2020;127:104362. ID - ref47 ER - TY - STD TI - Glebov OO. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing [published online ahead of print, 2020 May 19]. FEBS J. 2020;https://doi.org/10.1111/febs.15369. ID - ref48 ER - TY - STD TI - Magrone T, Magrone M, Jirillo E. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective [published online ahead of print, 2020 Apr 27]. Endocr Metab Immune Disord Drug Targets. 2020;https://doi.org/10.2174/1871530320666200427112902. ID - ref49 ER - TY - STD TI - Annweiler C, Cao Z, Wu Y, et al. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients [published online ahead of print, 2020 May 17]. Infect Disord Drug Targets. 2020;https://doi.org/10.2174/1871526520666200518073329. ID - ref50 ER - TY - STD TI - Offringa A, Montijn R, Singh S, Paul M, Pinto YM, Pinto-Sietsma SJ. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system [published online ahead of print, 2020 May 28]. Eur Heart J Cardiovasc Pharmacother. 2020;pvaa053. ID - ref51 ER - TY - STD TI - Liu DD, Hsu YH, Chen HI. Endotoxin-induced acute lung injury is enhanced in rats with spontaneous hypertension. Clin Exp Pharmacol Physiol. 2007;34(1-2):61-69. ID - ref52 ER - TY - STD TI - Biggest COVID-19 trial tests repurposed drugs first. Nat Biotechnol. 2020;38(5):510. ID - ref53 ER - TY - STD TI - Shaughnessy AF. Old drugs, new tricks. BMJ. 2011;342:d741. ID - ref54 ER - TY - STD TI - O'Connor KA, Roth BL. Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat Rev Drug Discov. 2005;4(12):1005-1014. ID - ref55 ER - TY - STD TI - Mercorelli B, Palù G, Loregian A. Drug Repurposing for Viral Infectious Diseases: How Far Are We?. Trends Microbiol. 2018;26(10):865-876. ID - ref56 ER - TY - STD TI - Pandey A, Nikam AN, Shreya AB, et al. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements [published online ahead of print, 2020 Jun 1]. Life Sci. 2020;256:117883. doi:https://doi.org/10.1016/j.lfs.2020.117883. ID - ref57 ER - TY - STD TI - Mazzanti A, Briani M, Kukavica D, et al. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 [published online ahead of print, 2020 Jun 5]. Circulation. 2020; https://doi.org/10.1161/CIRCULATIONAHA.120.048476. ID - ref58 ER - TY - STD TI - Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol2020;March 27:[Epub ahead of print]. ID - ref59 ER - TY - STD TI - Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA2020;March 19:[Epub ahead of print]. ID - ref60 ER - TY - STD TI - Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;March 27:[Epub ahead of print]. ID - ref61 ER - TY - STD TI - Mokra D, Mikolka P, Kosutova P, Mokry J. Corticosteroids in Acute Lung Injury: The Dilemma Continues. Int J Mol Sci. 2019;20(19):4765. Published 2019 Sep 25. ID - ref62 ER - TY - STD TI - Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37(5):1594-1603. ID - ref63 ER - TY - STD TI - Horby P, Lim WS, et al (RECOVERY Collaborative Group). Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report [published online ahead of print, 2020 Jul 17]. N Engl J Med. 2020;https://doi.org/10.1056/NEJMoa2021436. ID - ref64 ER - TY - STD TI - ClinicalTrials.gov (Last accessed July 23rd, 2020). ID - ref65 ER - TY - STD TI - Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393. ID - ref66 ER - TY - STD TI - Ma SQ, Zhang J, Wang YS, et al. Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient [published online ahead of print, 2020 May 29]. J Med Virol. 2020;https://doi.org/10.1002/jmv.26086. ID - ref67 ER - TY - STD TI - Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473-475. ID - ref68 ER - TY - STD TI - Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683-684. ID - ref69 ER - TY - STD TI - Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. Published 2020 May 7. ID - ref70 ER - TY - STD TI - Qin YY, Zhou YH, Lu YQ, et al. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial. Chin Med J (Engl). 2020;133(9):1080-1086. ID - ref71 ER - TY - STD TI - Wang Y, Jiang W, He Q, et al. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther. 2020;5(1):57. Published 2020 Apr 28. doi:https://doi.org/10.1038/s41392-020-0158-2. ID - ref72 ER - TY - STD TI - Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]. JAMA Intern Med. 2020;e200994. ID - ref73 ER - TY - STD TI - Zhou W, Liu Y, Tian D, et al. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduct Target Ther. 2020;5(1):18. Published 2020 Feb 21. ID - ref74 ER - TY - JOUR AU - Wyrwoll, C. S. AU - Mark, P. J. AU - Waddell, B. J. PY - 2007 DA - 2007// TI - Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system JO - Hypertension. VL - 50 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.091603 DO - 10.1161/HYPERTENSIONAHA.107.091603 ID - Wyrwoll2007 ER - TY - JOUR AU - Yongtao, Z. AU - Kunzheng, W. AU - Jingjing, Z. PY - 2014 DA - 2014// TI - Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis JO - Endocrine. VL - 47 UR - https://doi.org/10.1007/s12020-014-0196-z DO - 10.1007/s12020-014-0196-z ID - Yongtao2014 ER - TY - JOUR AU - Kino, T. AU - Chrousos, G. P. PY - 2004 DA - 2004// TI - Glucocorticoid and mineralocorticoid receptors and associated diseases JO - Essays Biochem. VL - 40 UR - https://doi.org/10.1042/bse0400137 DO - 10.1042/bse0400137 ID - Kino2004 ER - TY - JOUR AU - Fuller, P. J. AU - Lim-Tio, S. S. AU - Brennan, F. E. PY - 2000 DA - 2000// TI - Specificity in mineralocorticoid versus glucocorticoid action JO - Kidney Int. VL - 57 UR - https://doi.org/10.1046/j.1523-1755.2000.00959.x DO - 10.1046/j.1523-1755.2000.00959.x ID - Fuller2000 ER - TY - JOUR AU - Rashid, S. AU - Lewis, G. F. PY - 2005 DA - 2005// TI - The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues JO - Clin Biochem. VL - 38 UR - https://doi.org/10.1016/j.clinbiochem.2004.11.009 DO - 10.1016/j.clinbiochem.2004.11.009 ID - Rashid2005 ER - TY - JOUR AU - Pozzilli, P. AU - Lenzi, A. PY - 2020 DA - 2020// TI - Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic [published online ahead of print, 2020 Apr 27] JO - Metabolism. VL - 108 UR - https://doi.org/10.1016/j.metabol.2020.154252 DO - 10.1016/j.metabol.2020.154252 ID - Pozzilli2020 ER - TY - STD TI - Salonia A, Corona G, Giwercman A, et al. SARS-CoV-2, Testosterone and frailty in males (PROTEGGIMI): A multidimensional research project [published online ahead of print, 2020 May 5]. Andrology. 2020;https://doi.org/10.1111/andr.12811. ID - ref81 ER - TY - STD TI - Wambier CG, Vaño-Galván S, McCoy J, et al. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign" [published online ahead of print, 2020 May 21]. J Am Acad Dermatol. 2020;S0190-9622(20)30948-8. ID - ref82 ER - TY - STD TI - Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated [published online ahead of print, 2020 Apr 10]. J Am Acad Dermatol. 2020;S0190-9622(20)30608-3. ID - ref83 ER - TY - STD TI - McCoy J, Wambier CG, Vano-Galvan S, et al. Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19? [published online ahead of print, 2020 Apr 25]. J Cosmet Dermatol. 2020;https://doi.org/10.1111/jocd.13455. ID - ref84 ER - TY - STD TI - Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) [published online ahead of print, 2020 May 6]. Ann Oncol. 2020;S0923-7534(20)39797-0. ID - ref85 ER - TY - STD TI - Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. J Virol. 2019;93(6):e01815-18. Published 2019 Mar 5. ID - ref86 ER - TY - JOUR AU - Maric-Bilkan, C. AU - Manigrasso, M. B. PY - 2012 DA - 2012// TI - Sex differences in hypertension: contribution of the renin-angiotensin system JO - Gend Med. VL - 9 UR - https://doi.org/10.1016/j.genm.2012.06.005 DO - 10.1016/j.genm.2012.06.005 ID - Maric-Bilkan2012 ER - TY - JOUR AU - Arefi, S. AU - Mottaghi, S. AU - Sharifi, A. M. PY - 2013 DA - 2013// TI - Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs) JO - Gynecol Endocrinol. VL - 29 UR - https://doi.org/10.3109/09513590.2013.769513 DO - 10.3109/09513590.2013.769513 ID - Arefi2013 ER - TY - JOUR AU - Mishra, J. S. AU - More, A. S. AU - Gopalakrishnan, K. AU - Kumar, S. PY - 2019 DA - 2019// TI - Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats JO - Biol Reprod. VL - 100 UR - https://doi.org/10.1093/biolre/ioy179 DO - 10.1093/biolre/ioy179 ID - Mishra2019 ER - TY - JOUR AU - Georgianos, P. I. AU - Vaios, V. AU - Eleftheriadis, T. AU - Zebekakis, P. AU - Liakopoulos, V. PY - 2017 DA - 2017// TI - Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence JO - Curr Vasc Pharmacol. VL - 15 UR - https://doi.org/10.2174/1570161115666170201113817 DO - 10.2174/1570161115666170201113817 ID - Georgianos2017 ER - TY - JOUR AU - Hermidorff, M. M. AU - Faria Gde, O. AU - Amâncio Gde, C. AU - Assis, L. V. AU - Isoldi, M. C. PY - 2015 DA - 2015// TI - Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? JO - Biochem Cell Biol. VL - 93 UR - https://doi.org/10.1139/bcb-2014-0110 DO - 10.1139/bcb-2014-0110 ID - Hermidorff2015 ER - TY - STD TI - Cadegiani FA. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?. Am J Physiol. ID - ref92 ER - TY - JOUR AU - Nakano, S. AU - Kobayashi, N. AU - Yoshida, K. AU - Ohno, T. AU - Matsuoka, H. PY - 2005 DA - 2005// TI - Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats JO - Hypertens Res. VL - 28 UR - https://doi.org/10.1291/hypres.28.925 DO - 10.1291/hypres.28.925 ID - Nakano2005 ER - TY - JOUR AU - Dieterich, H. A. AU - Wendt, C. AU - Saborowski, F. PY - 2005 DA - 2005// TI - Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure JO - Fiziol Cheloveka. VL - 31 ID - Dieterich2005 ER - TY - JOUR AU - Taira, M. AU - Toba, H. AU - Murakami, M. PY - 2008 DA - 2008// TI - Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats JO - Eur J Pharmacol. VL - 589 UR - https://doi.org/10.1016/j.ejphar.2008.06.019 DO - 10.1016/j.ejphar.2008.06.019 ID - Taira2008 ER - TY - JOUR AU - Schjoedt, K. J. PY - 2011 DA - 2011// TI - The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: main focus on the role of aldosterone JO - Dan Med Bull. VL - 58 ID - Schjoedt2011 ER - TY - JOUR AU - Kong, E. L. AU - Zhang, J. M. AU - An, N. AU - Tao, Y. AU - Yu, W. F. AU - Wu, F. X. PY - 2019 DA - 2019// TI - Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression JO - J Cell Commun Signal. VL - 13 UR - https://doi.org/10.1007/s12079-018-0466-2 DO - 10.1007/s12079-018-0466-2 ID - Kong2019 ER - TY - JOUR AU - Takeda, Y. AU - Zhu, A. AU - Yoneda, T. AU - Usukura, M. AU - Takata, H. AU - Yamagishi, M. PY - 2007 DA - 2007// TI - Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats JO - Am J Hypertens. VL - 20 UR - https://doi.org/10.1016/j.amjhyper.2007.05.008 DO - 10.1016/j.amjhyper.2007.05.008 ID - Takeda2007 ER - TY - JOUR AU - Zhu, A. AU - Yoneda, T. AU - Demura, M. PY - 2009 DA - 2009// TI - Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats JO - J Hypertens. VL - 27 UR - https://doi.org/10.1097/HJH.0b013e328325d861 DO - 10.1097/HJH.0b013e328325d861 ID - Zhu2009 ER - TY - JOUR AU - Keidar, S. AU - Gamliel-Lazarovich, A. AU - Kaplan, M. PY - 2005 DA - 2005// TI - Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients JO - Circ Res. VL - 97 UR - https://doi.org/10.1161/01.RES.0000187500.24964.7A DO - 10.1161/01.RES.0000187500.24964.7A ID - Keidar2005 ER - TY - JOUR AU - Riet, L. AU - Esch, J. H. AU - Roks, A. J. AU - Meiracker, A. H. AU - Danser, A. H. PY - 2015 DA - 2015// TI - Hypertension: renin-angiotensin-aldosterone system alterations JO - Circ Res. VL - 116 UR - https://doi.org/10.1161/CIRCRESAHA.116.303587 DO - 10.1161/CIRCRESAHA.116.303587 ID - Riet2015 ER - TY - JOUR AU - Hamming, I. AU - Cooper, M. E. AU - Haagmans, B. L. PY - 2007 DA - 2007// TI - The emerging role of ACE2 in physiology and disease JO - J Pathol. VL - 212 UR - https://doi.org/10.1002/path.2162 DO - 10.1002/path.2162 ID - Hamming2007 ER - TY - JOUR AU - Patel, S. AU - Rauf, A. AU - Khan, H. AU - Abu-Izneid, T. PY - 2017 DA - 2017// TI - Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies JO - Biomed Pharmacother. VL - 94 UR - https://doi.org/10.1016/j.biopha.2017.07.091 DO - 10.1016/j.biopha.2017.07.091 ID - Patel2017 ER - TY - JOUR AU - South, A. M. AU - Diz, D. I. AU - Chappell, M. C. PY - 2020 DA - 2020// TI - COVID-19, ACE2, and the cardiovascular consequences JO - Am J Physiol Heart Circ Physiol. VL - 318 UR - https://doi.org/10.1152/ajpheart.00217.2020 DO - 10.1152/ajpheart.00217.2020 ID - South2020 ER - TY - JOUR AU - Sert, M. AU - Tetiker, T. AU - Kirim, S. PY - 2003 DA - 2003// TI - Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism JO - Acta Med Okayama. VL - 57 ID - Sert2003 ER - TY - JOUR AU - Steelman, S. L. AU - Brooks, J. R. AU - Morgan, E. R. AU - Patanelli, D. J. PY - 1969 DA - 1969// TI - Anti-androgenic activity of spironolactone JO - Steroids. VL - 14 UR - https://doi.org/10.1016/S0039-128X(69)80007-3 DO - 10.1016/S0039-128X(69)80007-3 ID - Steelman1969 ER - TY - JOUR AU - Broulik, P. D. AU - Stárka, L. PY - 1976 DA - 1976// TI - Antiandrogenic and antirenotropic effect of spironolactone JO - Endokrinologie. VL - 68 ID - Broulik1976 ER - TY - STD TI - Vecchiola A, Fuentes CA, Solar I, et al. Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division. Front Endocrinol (Lausanne). 2020;11:223. Published 2020 Apr 21. ID - ref108 ER - TY - JOUR AU - Feraco, A. AU - Armani, A. AU - Mammi, C. AU - Fabbri, A. AU - Rosano, G. M. AU - Caprio, M. PY - 2013 DA - 2013// TI - Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity JO - J Steroid Biochem Mol Biol. VL - 137 UR - https://doi.org/10.1016/j.jsbmb.2013.02.012 DO - 10.1016/j.jsbmb.2013.02.012 ID - Feraco2013 ER - TY - JOUR AU - Ji, W. J. AU - Ma, Y. Q. AU - Zhang, X. PY - 2016 DA - 2016// TI - Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice JO - Nanomedicine (Lond). VL - 11 UR - https://doi.org/10.2217/nnm-2016-0006 DO - 10.2217/nnm-2016-0006 ID - Ji2016 ER - TY - STD TI - SP-mediated mineralocorticoid receptor antagonism contributes to inflammatory monocyte/macrophage modulation via an inhibitory effect on Ly6C(hi) monocytosis-directed M2 polarization of alveolar macrophage. ID - ref111 ER - TY - STD TI - Ji WJ, Ma YQ, Zhou X, et al. Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments. PLoS One. 2013;8(11):e81090. Published 2013 Nov 19. doi:https://doi.org/10.1371/journal.pone.0081090. ID - ref112 ER - TY - JOUR AU - Rafatian, N. AU - Westcott, K. V. AU - White, R. A. AU - Leenen, F. H. PY - 2014 DA - 2014// TI - Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade JO - Am J Physiol Regul Integr Comp Physiol. VL - 307 UR - https://doi.org/10.1152/ajpregu.00075.2014 DO - 10.1152/ajpregu.00075.2014 ID - Rafatian2014 ER - TY - JOUR AU - Zhang, L. AU - Hao, J. B. AU - Ren, L. S. AU - Ding, J. L. AU - Hao, L. R. PY - 2014 DA - 2014// TI - The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis JO - Lab Invest. VL - 94 UR - https://doi.org/10.1038/labinvest.2014.69 DO - 10.1038/labinvest.2014.69 ID - Zhang2014 ER - TY - JOUR AU - Ozacmak, H. S. AU - Ozacmak, V. H. AU - Barut, F. AU - Araslı, M. AU - Ucan, B. H. PY - 2014 DA - 2014// TI - Pretreatment with mineralocorticoid receptor blocker reduces intestinal injury induced by ischemia and reperfusion: involvement of inhibition of inflammatory response, oxidative stress, nuclear factor κB, and inducible nitric oxide synthase JO - J Surg Res. VL - 191 UR - https://doi.org/10.1016/j.jss.2014.04.040 DO - 10.1016/j.jss.2014.04.040 ID - Ozacmak2014 ER - TY - JOUR AU - Kato, Y. AU - Kamiya, H. AU - Koide, N. PY - 2014 DA - 2014// TI - Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB JO - Immunopharmacol Immunotoxicol. VL - 36 UR - https://doi.org/10.3109/08923973.2014.921690 DO - 10.3109/08923973.2014.921690 ID - Kato2014 ER - TY - JOUR AU - Lieber, G. B. AU - Fernandez, X. AU - Mingo, G. G. PY - 2013 DA - 2013// TI - Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models JO - Eur J Pharmacol. VL - 718 UR - https://doi.org/10.1016/j.ejphar.2013.08.019 DO - 10.1016/j.ejphar.2013.08.019 ID - Lieber2013 ER - TY - JOUR AU - Fraccarollo, D. AU - Galuppo, P. AU - Schraut, S. PY - 2008 DA - 2008// TI - Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response JO - Hypertension. VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.107.100941 DO - 10.1161/HYPERTENSIONAHA.107.100941 ID - Fraccarollo2008 ER - TY - STD TI - Lacombe B, Morel M, Margottin-Goguet F, Ramirez BC. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. J Virol. 2016;90(23):10972-10980. Published 2016 Nov 14. doi:https://doi.org/10.1128/JVI.01722-16. ID - ref119 ER - TY - JOUR AU - Verma, D. AU - Thompson, J. AU - Swaminathan, S. PY - 2016 DA - 2016// TI - Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function JO - Proc Natl Acad Sci U S A. VL - 113 UR - https://doi.org/10.1073/pnas.1523686113 DO - 10.1073/pnas.1523686113 ID - Verma2016 ER - TY - STD TI - Yartaş Dumanlı G, Dilken O, Ürkmez S. Use of Spironolactone in SARS-CoV-2 ARDS Patients. Turk J Anaesthesiol Reanim 30 April 2020; DOI: 10.5152/ TJAR.2020.569. ID - ref121 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04345887 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04345887?term=spironolactone+COVID&draw=2&rank=2 ID - ref122 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04424134 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04424134?term=spironolactone+COVID&draw=2&rank=1 ID - ref123 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04467931 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04467931 ID - ref124 ER - TY - JOUR AU - Rozner, R. N. AU - Freites-Martinez, A. AU - Shapiro, J. AU - Geer, E. B. AU - Goldfarb, S. AU - Lacouture, M. E. PY - 2019 DA - 2019// TI - Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies JO - Breast Cancer Res Treat. VL - 174 UR - https://doi.org/10.1007/s10549-018-4996-3 DO - 10.1007/s10549-018-4996-3 ID - Rozner2019 ER - TY - JOUR AU - Almohanna, H. M. AU - Perper, M. AU - Tosti, A. PY - 2018 DA - 2018// TI - Safety concerns when using novel medications to treat alopecia JO - Expert Opin Drug Saf. VL - 17 UR - https://doi.org/10.1080/14740338.2018.1533549 DO - 10.1080/14740338.2018.1533549 ID - Almohanna2018 ER - TY - JOUR AU - Andriole, G. L. AU - Kirby, R. PY - 2003 DA - 2003// TI - Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia JO - Eur Urol. VL - 44 UR - https://doi.org/10.1016/S0302-2838(03)00198-2 DO - 10.1016/S0302-2838(03)00198-2 ID - Andriole2003 ER - TY - JOUR AU - Mostaghel, E. A. AU - Geng, L. AU - Holcomb, I. PY - 2010 DA - 2010// TI - Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention JO - Cancer Res. VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2509 DO - 10.1158/0008-5472.CAN-09-2509 ID - Mostaghel2010 ER - TY - JOUR AU - Wu, Y. AU - Godoy, A. AU - Azzouni, F. AU - Wilton, J. H. AU - Ip, C. AU - Mohler, J. L. PY - 2013 DA - 2013// TI - Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors JO - Prostate. VL - 73 UR - https://doi.org/10.1002/pros.22694 DO - 10.1002/pros.22694 ID - Wu2013 ER - TY - JOUR AU - Tindall, D. J. AU - Rittmaster, R. S. PY - 2008 DA - 2008// TI - The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer [published correction appears in J Urol. 2008 Jun;179(6):2490] JO - J Urol. VL - 179 UR - https://doi.org/10.1016/j.juro.2007.11.033 DO - 10.1016/j.juro.2007.11.033 ID - Tindall2008 ER - TY - STD TI - Ghazizadeh Z, Majd H, Richter M, et al. Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Preprint. bioRxiv. 2020;2020.05.12.091082. Published 2020 May 15. doi:https://doi.org/10.1101/2020.05.12.091082. ID - ref131 ER - TY - STD TI - Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Am Acad Derm. In review. ID - ref132 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04446429 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04446429 ID - ref133 ER - TY - JOUR AU - Bedi, O. AU - Dhawan, V. AU - Sharma, P. L. AU - Kumar, P. PY - 2016 DA - 2016// TI - Pleiotropic effects of statins: new therapeutic targets in drug design JO - Naunyn Schmiedebergs Arch Pharmacol. VL - 389 UR - https://doi.org/10.1007/s00210-016-1252-4 DO - 10.1007/s00210-016-1252-4 ID - Bedi2016 ER - TY - JOUR AU - Zhou, Q. AU - Liao, J. K. PY - 2009 DA - 2009// TI - Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy JO - Curr Pharm Des. VL - 15 UR - https://doi.org/10.2174/138161209787315684 DO - 10.2174/138161209787315684 ID - Zhou2009 ER - TY - JOUR AU - Williams, E. A. AU - Russo, V. AU - Ceraso, S. AU - Gupta, D. AU - Barrett-Jolley, R. PY - 2020 DA - 2020// TI - Anti-arrhythmic properties of non-antiarrhythmic medications JO - Pharmacol Res. VL - 156 UR - https://doi.org/10.1016/j.phrs.2020.104762 DO - 10.1016/j.phrs.2020.104762 ID - Williams2020 ER - TY - JOUR AU - Fan, E. AU - Brodie, D. AU - Slutsky, A. S. PY - 2018 DA - 2018// TI - Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment JO - JAMA. VL - 319 UR - https://doi.org/10.1001/jama.2017.21907 DO - 10.1001/jama.2017.21907 ID - Fan2018 ER - TY - JOUR AU - Feng, Y. PY - 2018 DA - 2018// TI - Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis JO - Eur Rev Med Pharmacol Sci. VL - 22 ID - Feng2018 ER - TY - JOUR AU - Xiong, B. AU - Wang, C. AU - Tan, J. PY - 2016 DA - 2016// TI - Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis JO - Respirology. VL - 21 UR - https://doi.org/10.1111/resp.12820 DO - 10.1111/resp.12820 ID - Xiong2016 ER - TY - JOUR AU - Yin, J. AU - Bai, C. X. PY - 2018 DA - 2018// TI - Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome JO - Chin Med J (Engl). VL - 131 UR - https://doi.org/10.4103/0366-6999.231520 DO - 10.4103/0366-6999.231520 ID - Yin2018 ER - TY - JOUR AU - Grommes, J. AU - Vijayan, S. AU - Drechsler, M. PY - 2012 DA - 2012// TI - Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation JO - PLoS One. VL - 7 UR - https://doi.org/10.1371/journal.pone.0038917 DO - 10.1371/journal.pone.0038917 ID - Grommes2012 ER - TY - STD TI - Fedson DS, Opal SM, Rordam OM. Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection. mBio. 2020;11(2):e00398-20. Published 2020 Mar 20. ID - ref142 ER - TY - STD TI - Castiglione V, Chiriacò M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection [published online ahead of print, 2020 Apr 29]. Eur Heart J Cardiovasc Pharmacother. 2020;pvaa042. ID - ref143 ER - TY - JOUR AU - Alijotas-Reig, J. AU - Esteve-Valverde, E. AU - Belizna, C. PY - 2020 DA - 2020// TI - Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review JO - Autoimmun Rev. VL - 19 UR - https://doi.org/10.1016/j.autrev.2020.102569 DO - 10.1016/j.autrev.2020.102569 ID - Alijotas-Reig2020 ER - TY - STD TI - Reiner Ž, Hatamipour M, Banach M, et al. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci. 2020;16(3):490-496. Published 2020 Apr 25. ID - ref145 ER - TY - JOUR AU - Baudrand, R. AU - Pojoga, L. H. AU - Vaidya, A. PY - 2015 DA - 2015// TI - Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects JO - Circulation. VL - 132 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.016759 DO - 10.1161/CIRCULATIONAHA.115.016759 ID - Baudrand2015 ER - TY - JOUR AU - Borghi, C. AU - Urso, R. AU - Cicero, A. F. PY - 2017 DA - 2017// TI - Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia JO - Nutr Metab Cardiovasc Dis. VL - 27 UR - https://doi.org/10.1016/j.numecd.2016.07.013 DO - 10.1016/j.numecd.2016.07.013 ID - Borghi2017 ER - TY - JOUR AU - Drapala, A. AU - Sikora, M. AU - Ufnal, M. PY - 2014 DA - 2014// TI - Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins JO - J Renin Angiotensin Aldosterone Syst. VL - 15 UR - https://doi.org/10.1177/1470320314531058 DO - 10.1177/1470320314531058 ID - Drapala2014 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04407273 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04407273 ID - ref149 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04348695 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04348695 ID - ref150 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04466241 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04466241 ID - ref151 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04380402 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04380402 ID - ref152 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04343001 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04343001 ID - ref153 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04472611 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04472611 ID - ref154 ER - TY - STD TI - Jakovac H. COVID-19 and vitamin D-Is there a link and an opportunity for intervention?. Am J Physiol Endocrinol Metab. 2020;318(5):E589. doi:https://doi.org/10.1152/ajpendo.00138.2020. ID - ref155 ER - TY - STD TI - Facchiano A, Facchiano A, Bartoli M, Ricci A, Facchiano F. Reply to Jakovac: About COVID-19 and vitamin D. Am J Physiol Endocrinol Metab. 2020;318(6):E838. ID - ref156 ER - TY - STD TI - Aygun H. Vitamin D can prevent COVID-19 infection-induced multiple organ damage [published online ahead of print, 2020 May 25]. Naunyn Schmiedebergs Arch Pharmacol. 2020;1-4. ID - ref157 ER - TY - STD TI - Speeckaert MM, Delanghe JR. Association between low vitamin D and COVID-19: don't forget the vitamin D binding protein [published online ahead of print, 2020 May 28]. Aging Clin Exp Res. 2020;https://doi.org/10.1007/s40520-020-01607-y. ID - ref158 ER - TY - STD TI - Glinsky GV. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines. 2020;8(5):E129. Published 2020 May 21. ID - ref159 ER - TY - STD TI - Grant WB, Lahore H, McDonnell SL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4):988. Published 2020 Apr 2. ID - ref160 ER - TY - JOUR AU - Teymoori-Rad, M. AU - Shokri, F. AU - Salimi, V. AU - Marashi, S. M. PY - 2019 DA - 2019// TI - The interplay between vitamin D and viral infections JO - Rev Med Virol. VL - 29 UR - https://doi.org/10.1002/rmv.2032 DO - 10.1002/rmv.2032 ID - Teymoori-Rad2019 ER - TY - STD TI - Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1). https://doi.org/10.1002/rmv.1909. ID - ref162 ER - TY - STD TI - de Sa Del Fiol F, Barberato-Filho S, Lopes LC, de Cassia Bergamaschi C. Vitamin D and respiratory infections. J Infect Dev Ctries. 2015;9(4):355-361. Published 2015 Apr 15. ID - ref163 ER - TY - JOUR AU - Bartley, J. PY - 2010 DA - 2010// TI - Vitamin D, innate immunity and upper respiratory tract infection JO - J Laryngol Otol. VL - 124 UR - https://doi.org/10.1017/S0022215109992684 DO - 10.1017/S0022215109992684 ID - Bartley2010 ER - TY - STD TI - Gruber-Bzura BM. Vitamin D and Influenza-Prevention or Therapy?. Int J Mol Sci. 2018;19(8):2419. Published 2018 Aug 16. ID - ref165 ER - TY - JOUR AU - Beard, J. A. AU - Bearden, A. AU - Striker, R. PY - 2011 DA - 2011// TI - Vitamin D and the anti-viral state JO - J Clin Virol. VL - 50 UR - https://doi.org/10.1016/j.jcv.2010.12.006 DO - 10.1016/j.jcv.2010.12.006 ID - Beard2011 ER - TY - JOUR AU - Hastie, C. E. AU - Mackay, D. F. AU - Ho, F. PY - 2020 DA - 2020// TI - Vitamin D concentrations and COVID-19 infection in UK Biobank [published online ahead of print, 2020 May 7] JO - Diabetes Metab Syndr. VL - 14 UR - https://doi.org/10.1016/j.dsx.2020.04.050 DO - 10.1016/j.dsx.2020.04.050 ID - Hastie2020 ER - TY - JOUR AU - Xu, J. AU - Yang, J. AU - Chen, J. AU - Luo, Q. AU - Zhang, Q. AU - Zhang, H. PY - 2017 DA - 2017// TI - Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system JO - Mol Med Rep. VL - 16 UR - https://doi.org/10.3892/mmr.2017.7546 DO - 10.3892/mmr.2017.7546 ID - Xu2017 ER - TY - JOUR AU - Wang, D. AU - Chai, X. Q. AU - Magnussen, C. G. PY - 2019 DA - 2019// TI - Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation JO - Pulm Pharmacol Ther. VL - 58 UR - https://doi.org/10.1016/j.pupt.2019.101833 DO - 10.1016/j.pupt.2019.101833 ID - Wang2019 ER - TY - JOUR AU - Shi, Y. Y. AU - Liu, T. J. AU - Fu, J. H. PY - 2016 DA - 2016// TI - Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier JO - Mol Med Rep. VL - 13 UR - https://doi.org/10.3892/mmr.2015.4685 DO - 10.3892/mmr.2015.4685 ID - Shi2016 ER - TY - JOUR AU - Zheng, S. AU - Yang, J. AU - Hu, X. PY - 2020 DA - 2020// TI - Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition [published online ahead of print, 2020 Apr 3] JO - Biochem Pharmacol. VL - 113955 ID - Zheng2020 ER - TY - JOUR AU - Klaff, L. S. AU - Gill, S. E. AU - Wisse, B. E. PY - 2012 DA - 2012// TI - Lipopolysaccharide-induced lung injury is independent of serum vitamin D concentration JO - PLoS One. VL - 7 UR - https://doi.org/10.1371/journal.pone.0049076 DO - 10.1371/journal.pone.0049076 ID - Klaff2012 ER - TY - STD TI - Barnett N, Zhao Z, Koyama T, et al. Vitamin D deficiency and risk of acute lung injury in severe sepsis and severe trauma: a case-control study. Ann Intensive Care. 2014;4(1):5. Published 2014 Feb 24. ID - ref173 ER - TY - JOUR AU - Li, Y. C. AU - Kong, J. AU - Wei, M. AU - Chen, Z. F. AU - Liu, S. Q. AU - Cao, L. P. PY - 2002 DA - 2002// TI - 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system JO - J Clin Invest. VL - 110 UR - https://doi.org/10.1172/JCI0215219 DO - 10.1172/JCI0215219 ID - Li2002 ER - TY - STD TI - Leung PS. The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. Molecules. 2019;24(13):2479. Published 2019 Jul 5. ID - ref175 ER - TY - JOUR AU - Turin, A. AU - Bax, J. J. AU - Doukas, D. PY - 2018 DA - 2018// TI - Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System JO - Am J Cardiol. VL - 122 UR - https://doi.org/10.1016/j.amjcard.2018.05.013 DO - 10.1016/j.amjcard.2018.05.013 ID - Turin2018 ER - TY - JOUR AU - McMullan, C. J. AU - Borgi, L. AU - Curhan, G. C. AU - Fisher, N. AU - Forman, J. P. PY - 2017 DA - 2017// TI - The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial JO - J Hypertens. VL - 35 UR - https://doi.org/10.1097/HJH.0000000000001220 DO - 10.1097/HJH.0000000000001220 ID - McMullan2017 ER - TY - JOUR AU - Washington, M. N. PY - 2010 DA - 2010// TI - Weigel NL. 1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion JO - Endocrinology. VL - 151 UR - https://doi.org/10.1210/en.2009-0991 DO - 10.1210/en.2009-0991 ID - Washington2010 ER - TY - JOUR AU - Murthy, S. AU - Agoulnik, I. U. AU - Weigel, N. L. PY - 2005 DA - 2005// TI - Androgen receptor signaling and vitamin D receptor action in prostate cancer cells JO - Prostate. VL - 64 UR - https://doi.org/10.1002/pros.20251 DO - 10.1002/pros.20251 ID - Murthy2005 ER - TY - JOUR AU - Mokhtari, V. AU - Afsharian, P. AU - Shahhoseini, M. AU - Kalantar, S. M. AU - Moini, A. PY - 2017 DA - 2017// TI - A Review on Various Uses of N-Acetyl Cysteine JO - Cell J. VL - 19 UR - https://doi.org/10.22074/cellj.2016.4872 DO - 10.22074/cellj.2016.4872 ID - Mokhtari2017 ER - TY - JOUR AU - Sekhar, R. V. AU - Patel, S. G. AU - Guthikonda, A. P. AU - Reid, M. AU - Balasubramanyam, A. AU - Taffet, G. E. PY - 2011 DA - 2011// TI - Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation JO - Am J Clin Nutr. VL - 94 UR - https://doi.org/10.3945/ajcn.110.003483 DO - 10.3945/ajcn.110.003483 ID - Sekhar2011 ER - TY - JOUR AU - Circu, M. L. AU - Aw, T. Y. PY - 2008 DA - 2008// TI - Glutathione and apoptosis JO - Free Radic Res. VL - 42 UR - https://doi.org/10.1080/10715760802317663 DO - 10.1080/10715760802317663 ID - Circu2008 ER - TY - JOUR AU - Whillier, S. AU - Raftos, J. E. AU - Chapman, B. AU - Kuchel, P. W. PY - 2009 DA - 2009// TI - Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes JO - Redox Rep. VL - 14 UR - https://doi.org/10.1179/135100009X392539 DO - 10.1179/135100009X392539 ID - Whillier2009 ER - TY - JOUR AU - Sekhar, R. V. AU - McKay, S. V. AU - Patel, S. G. AU - Guthikonda, A. P. AU - Reddy, V. T. AU - Balasubramanyam, A. PY - 2011 DA - 2011// TI - Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine JO - Diabetes Care. VL - 34 UR - https://doi.org/10.2337/dc10-1006 DO - 10.2337/dc10-1006 ID - Sekhar2011 ER - TY - JOUR AU - Kavanagh, T. J. AU - Grossmann, A. AU - Jaecks, E. P. AU - Jinneman, J. C. AU - Eaton, D. L. AU - Martin, G. M. PY - 1990 DA - 1990// TI - Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content JO - J Cell Physiol. VL - 145 UR - https://doi.org/10.1002/jcp.1041450312 DO - 10.1002/jcp.1041450312 ID - Kavanagh1990 ER - TY - JOUR AU - Kao, S. J. AU - Wang, D. AU - Lin, H. I. AU - Chen, H. I. PY - 2006 DA - 2006// TI - N-acetylcysteine abrogates acute lung injury induced by endotoxin JO - Clin Exp Pharmacol Physiol. VL - 33 UR - https://doi.org/10.1111/j.1440-1681.2006.04320.x DO - 10.1111/j.1440-1681.2006.04320.x ID - Kao2006 ER - TY - JOUR AU - Shen, Y. AU - Miao, N. J. AU - Xu, J. L. PY - 2016 DA - 2016// TI - N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys JO - Acta Pharmacol Sin. VL - 37 UR - https://doi.org/10.1038/aps.2016.12 DO - 10.1038/aps.2016.12 ID - Shen2016 ER - TY - JOUR AU - Boesgaard, S. AU - Aldershvile, J. AU - Poulsen, H. E. AU - Christensen, S. AU - Dige-Petersen, H. AU - Giese, J. PY - 1993 DA - 1993// TI - N-acetylcysteine inhibits angiotensin converting enzyme in vivo JO - J Pharmacol Exp Ther. VL - 265 ID - Boesgaard1993 ER - TY - JOUR AU - Assimakopoulos, S. F. AU - Marangos, M. PY - 2020 DA - 2020// TI - N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome [published online ahead of print, 2020 Apr 22] JO - Med Hypotheses. VL - 140 UR - https://doi.org/10.1016/j.mehy.2020.109778 DO - 10.1016/j.mehy.2020.109778 ID - Assimakopoulos2020 ER - TY - JOUR AU - Andreou, A. AU - Trantza, S. AU - Filippou, D. AU - Sipsas, N. AU - Tsiodras, S. PY - 2020 DA - 2020// TI - COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2 JO - In Vivo. VL - 34 UR - https://doi.org/10.21873/invivo.11946 DO - 10.21873/invivo.11946 ID - Andreou2020 ER - TY - JOUR AU - Horowitz, R. I. AU - Freeman, P. R. PY - 2020 DA - 2020// TI - Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials [published online ahead of print, 2020 May 22] JO - Med Hypotheses. VL - 143 UR - https://doi.org/10.1016/j.mehy.2020.109851 DO - 10.1016/j.mehy.2020.109851 ID - Horowitz2020 ER - TY - STD TI - Poe FL, Corn J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2 [published online ahead of print, 2020 May 30]. Med Hypotheses. 2020;143:109862. ID - ref192 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04374461 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04374461 ID - ref193 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04419025 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04419025 ID - ref194 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04458298 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04458298 ID - ref195 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT0437028 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT0437028 ID - ref196 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04455243 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04455243 ID - ref197 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04466657 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04466657 ID - ref198 ER - TY - JOUR AU - Brotons, C. AU - Benamouzig, R. AU - Filipiak, K. J. AU - Limmroth, V. AU - Borghi, C. PY - 2015 DA - 2015// TI - A systematic review of aspirin in primary prevention: is it time for a new approach? JO - Am J Cardiovasc Drugs. VL - 15 UR - https://doi.org/10.1007/s40256-014-0100-5 DO - 10.1007/s40256-014-0100-5 ID - Brotons2015 ER - TY - STD TI - Win TT, Aye SN, Lau Chui Fern J, Ong Fei C. Aspirin and Reducing Risk of Gastric Cancer: Systematic Review and Meta-Analysis of the Observational Studies. J Gastrointestin Liver Dis. 2020;29(2):191-198. Published 2020 Jun 3. ID - ref200 ER - TY - STD TI - Tacconelli S, Contursi A, Falcone L, et al. Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems [published online ahead of print, 2020 Jun 11]. Biochem Pharmacol. 2020;114094. ID - ref201 ER - TY - JOUR AU - Burn, J. AU - Sheth, H. AU - Elliott, F. PY - 2020 DA - 2020// TI - Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30366-4 DO - 10.1016/S0140-6736(20)30366-4 ID - Burn2020 ER - TY - STD TI - Bem D, Dretzke J, Stevens S, et al. Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review. Syst Rev. 2015;4:88. Published 2015 Jun 19. ID - ref203 ER - TY - JOUR AU - Meune, C. AU - Mourad, J. J. AU - Bergmann, J. F. AU - Spaulding, C. PY - 2003 DA - 2003// TI - Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance JO - J Renin Angiotensin Aldosterone Syst. VL - 4 UR - https://doi.org/10.3317/jraas.2003.023 DO - 10.3317/jraas.2003.023 ID - Meune2003 ER - TY - JOUR AU - Nawarskas, J. J. AU - Spinler, S. A. PY - 1998 DA - 1998// TI - Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure? JO - Pharmacotherapy. VL - 18 ID - Nawarskas1998 ER - TY - STD TI - Gawrys J, Gawrys K, Szahidewicz-Krupska E, Derkacz A, Mochol J, Doroszko A. Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice. Biomed Res Int. 2018;2018:7902081. Published 2018 Oct 2. ID - ref206 ER - TY - JOUR AU - Yu, H. AU - Ni, Y. N. AU - Liang, Z. A. AU - Liang, B. M. AU - Wang, Y. PY - 2018 DA - 2018// TI - The effect of aspirin in preventing the acute respiratory distress syndrome/acute lung injury: A meta-analysis JO - Am J Emerg Med. VL - 36 UR - https://doi.org/10.1016/j.ajem.2018.05.017 DO - 10.1016/j.ajem.2018.05.017 ID - Yu2018 ER - TY - STD TI - Tilgner J, von Trotha KT, Gombert A, et al. Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury. PLoS One. 2016;11(9):e0161218. Published 2016 Sep 1. ID - ref208 ER - TY - STD TI - Liang H, Ding X, Li H, Li L, Sun T. Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020;11:738. Published 2020 May 19. ID - ref209 ER - TY - JOUR AU - Schuliga, M. AU - Jaffar, J. AU - Berhan, A. PY - 2017 DA - 2017// TI - Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity JO - Am J Physiol Lung Cell Mol Physiol. VL - 312 UR - https://doi.org/10.1152/ajplung.00553.2016 DO - 10.1152/ajplung.00553.2016 ID - Schuliga2017 ER - TY - JOUR AU - Shi, M. AU - Wang, L. AU - Zhou, J. PY - 2018 DA - 2018// TI - Direct factor Xa inhibition attenuates acute lung injury progression via modulation of the PAR-2/NF-κB signaling pathway JO - Am J Transl Res. VL - 10 ID - Shi2018 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04416048 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04416048 ID - ref212 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04324463 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04324463 ID - ref213 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04394377 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04394377 ID - ref214 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04333407 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04333407 ID - ref215 ER - TY - STD TI - Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell MC, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nature Med 2005; 11:875–87. ID - ref216 ER - TY - STD TI - Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565–574. ID - ref217 ER - TY - STD TI - Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, W Zuo. Single-cell RNA expression profiling of ACE-2, the putative receptor of wuhan 2019-ncov. 2020. bioRxiv, https://doi.org/10.1101/2020.01.26.919985. ID - ref218 ER - TY - STD TI - Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease [published online ahead of print, 2020 Feb 28]. Chin Med J (Engl). 2020;https://doi.org/10.1097/CM9.0000000000000775. ID - ref219 ER - TY - STD TI - Williams B, Zhang Y. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet. 2020;395(10238):1671-1673. ID - ref220 ER - TY - STD TI - South AM, Diz D, Chappell MC. COVID-19, ACE2 and the Cardiovascular Consequences [published online ahead of print, 2020 Mar 31]. Am J Physiol Heart Circ Physiol. 2020;https://doi.org/10.1152/ajpheart.00217.2020. ID - ref221 ER - TY - STD TI - Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 [published online ahead of print, 2020 Mar 30]. N Engl J Med. 2020;https://doi.org/10.1056/NEJMsr2005760. ID - ref222 ER - TY - STD TI - McKee DL, Sternberg A, Stange U, Laufer S, Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol Res. 2020;157:104859. doi:https://doi.org/10.1016/j.phrs.2020.104859. ID - ref223 ER - TY - STD TI - Gil C, Ginex T, Maestro I, et al. COVID-19: Drug targets and potential treatments [published online ahead of print, 2020 Jun 8]. J Med Chem. 2020;https://doi.org/10.1021/acs.jmedchem.0c00606. ID - ref224 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04357535 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04357535 ID - ref225 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04353596 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04353596 ID - ref226 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04329195 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04329195 ID - ref227 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04322786 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04322786 ID - ref228 ER - TY - STD TI - Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017;142:1-10. ID - ref229 ER - TY - STD TI - Uno Y. Camostat mesilate therapy for COVID-19 [published online ahead of print, 2020 Apr 29]. Intern Emerg Med. 2020;1-2. ID - ref230 ER - TY - STD TI - Lobo-Galo N, Terrazas-López M, Martínez-Martínez A, Díaz-Sánchez ÁG. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication [published online ahead of print, 2020 May 14]. ID - ref231 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04352400 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04352400 ID - ref232 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04418128 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04418128 ID - ref233 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04473053 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04473053 ID - ref234 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04353284 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04353284 ID - ref235 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04455815 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04455815 ID - ref236 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04338906 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04338906 ID - ref237 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04321096 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04321096 ID - ref238 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04435015 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04435015 ID - ref239 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04355052 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04355052 ID - ref240 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04470544 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04470544 ID - ref241 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04374019 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04374019 ID - ref242 ER - TY - STD TI - Rastrelli G, Di Stasi V, Inglese F, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients [published online ahead of print, 2020 May 20]. Andrology. 2020;https://doi.org/10.1111/andr.12821. ID - ref243 ER - TY - JOUR AU - Wright, T. J. AU - Dillon, E. L. AU - Durham, W. J. PY - 2018 DA - 2018// TI - A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women JO - J Cachexia Sarcopenia Muscle. VL - 9 UR - https://doi.org/10.1002/jcsm.12295 DO - 10.1002/jcsm.12295 ID - Wright2018 ER - TY - JOUR AU - Rolfe, M. AU - Kamel, A. AU - Ahmed, M. M. AU - Kramer, J. PY - 2019 DA - 2019// TI - Pharmacological management of cardiac cachexia: a review of potential therapy options JO - Heart Fail Rev. VL - 24 UR - https://doi.org/10.1007/s10741-019-09784-3 DO - 10.1007/s10741-019-09784-3 ID - Rolfe2019 ER - TY - JOUR AU - Springer, J. AU - Springer, J. I. AU - Anker, S. D. PY - 2017 DA - 2017// TI - Muscle wasting and sarcopenia in heart failure and beyond: update 2017 JO - ESC Heart Fail. VL - 4 UR - https://doi.org/10.1002/ehf2.12237 DO - 10.1002/ehf2.12237 ID - Springer2017 ER - TY - JOUR AU - Breithaupt-Faloppa, A. C. AU - Correia, C. J. AU - Prado, C. M. AU - Stilhano, R. S. AU - Ureshino, R. P. AU - Moreira, L. F. P. PY - 2020 DA - 2020// TI - 17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection JO - Clinics (Sao Paulo). VL - 75 UR - https://doi.org/10.6061/clinics/2020/e1980 DO - 10.6061/clinics/2020/e1980 ID - Breithaupt-Faloppa2020 ER - TY - STD TI - Grandi G, Facchinetti F, Bitzer J. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? [published online ahead of print, 2020 May 29]. Eur J Contracept Reprod Health Care. 2020;1-2. ID - ref248 ER - TY - JOUR AU - Suba, Z. PY - 2020 DA - 2020// TI - Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients JO - J Pharm Pharm Sci. VL - 23 UR - https://doi.org/10.18433/jpps31069 DO - 10.18433/jpps31069 ID - Suba2020 ER - TY - JOUR AU - Manning, J. T. AU - Fink, B. PY - 2020 DA - 2020// TI - Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates [published online ahead of print, 2020 May 14] JO - Early Hum Dev. VL - 146 UR - https://doi.org/10.1016/j.earlhumdev.2020.105074 DO - 10.1016/j.earlhumdev.2020.105074 ID - Manning2020 ER - TY - JOUR AU - Stelzig, K. E. AU - Canepa-Escaro, F. AU - Schiliro, M. AU - Berdnikovs, S. AU - Prakash, Y. S. AU - Chiarella, S. E. PY - 2020 DA - 2020// TI - Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells JO - Am J Physiol Lung Cell Mol Physiol. VL - 318 UR - https://doi.org/10.1152/ajplung.00153.2020 DO - 10.1152/ajplung.00153.2020 ID - Stelzig2020 ER - TY - JOUR AU - Stadio, A. AU - Della Volpe, A. AU - Ralli, M. PY - 2020 DA - 2020// TI - Ricci G. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment? JO - Eur Rev Med Pharmacol Sci. VL - 24 ID - Stadio2020 ER - TY - JOUR AU - Cutolo, M. AU - Smith, V. AU - Paolino, S. PY - 2020 DA - 2020// TI - Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination JO - Clin Exp Rheumatol. VL - 38 ID - Cutolo2020 ER - TY - STD TI - Doucet D, Badami C, Palange D, et al. Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats. PLoS One. 2010;5(2):e9421. Published 2010 Feb 25. ID - ref254 ER - TY - JOUR AU - Kan, W. H. AU - Hsu, J. T. AU - Schwacha, M. G. AU - Choudhry, M. A. AU - Bland, K. I. AU - Chaudry, I. H. PY - 2008 DA - 2008// TI - Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G JO - Ann Surg. VL - 248 UR - https://doi.org/10.1097/SLA.0b013e318180a3db DO - 10.1097/SLA.0b013e318180a3db ID - Kan2008 ER - TY - JOUR AU - Hamidi, S. A. AU - Dickman, K. G. AU - Berisha, H. AU - Said, S. I. PY - 2011 DA - 2011// TI - 17β-estradiol protects the lung against acute injury: possible mediation by vasoactive intestinal polypeptide JO - Endocrinology. VL - 152 UR - https://doi.org/10.1210/en.2011-1631 DO - 10.1210/en.2011-1631 ID - Hamidi2011 ER - TY - JOUR AU - Kawasaki, T. AU - Chaudry, I. H. PY - 2012 DA - 2012// TI - The effects of estrogen on various organs: therapeutic approach for sepsis, trauma, and reperfusion injury. Part 1: central nervous system, lung, and heart JO - J Anesth. VL - 26 UR - https://doi.org/10.1007/s00540-012-1425-3 DO - 10.1007/s00540-012-1425-3 ID - Kawasaki2012 ER - TY - JOUR AU - Speyer, C. L. AU - Rancilio, N. J. AU - McClintock, S. D. PY - 2005 DA - 2005// TI - Regulatory effects of estrogen on acute lung inflammation in mice JO - Am J Physiol Cell Physiol. VL - 288 UR - https://doi.org/10.1152/ajpcell.00467.2004 DO - 10.1152/ajpcell.00467.2004 ID - Speyer2005 ER - TY - JOUR AU - Vieira, R. F. AU - Breithaupt-Faloppa, A. C. AU - Matsubara, B. C. PY - 2018 DA - 2018// TI - 17β-Estradiol protects against lung injuries after brain death in male rats JO - J Heart Lung Transplant. VL - 37 UR - https://doi.org/10.1016/j.healun.2018.06.015 DO - 10.1016/j.healun.2018.06.015 ID - Vieira2018 ER - TY - JOUR AU - Komukai, K. AU - Mochizuki, S. AU - Yoshimura, M. PY - 2010 DA - 2010// TI - Gender and the renin-angiotensin-aldosterone system JO - Fundam Clin Pharmacol. VL - 24 UR - https://doi.org/10.1111/j.1472-8206.2010.00854.x DO - 10.1111/j.1472-8206.2010.00854.x ID - Komukai2010 ER - TY - JOUR AU - Hilliard, L. M. AU - Sampson, A. K. AU - Brown, R. D. AU - Denton, K. M. PY - 2013 DA - 2013// TI - The "his and hers" of the renin-angiotensin system JO - Curr Hypertens Rep. VL - 15 UR - https://doi.org/10.1007/s11906-012-0319-y DO - 10.1007/s11906-012-0319-y ID - Hilliard2013 ER - TY - JOUR AU - O'Donnell, E. AU - Floras, J. S. AU - Harvey, P. J. PY - 2014 DA - 2014// TI - Estrogen status and the renin angiotensin aldosterone system JO - Am J Physiol Regul Integr Comp Physiol. VL - 307 UR - https://doi.org/10.1152/ajpregu.00182.2014 DO - 10.1152/ajpregu.00182.2014 ID - O'Donnell2014 ER - TY - STD TI - Kim H, Datta A, Talwar S, Saleem SN, Mondal D, Abdel-Mageed AB. Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion. Oncotarget. 2016;8(38):62820-62833. Published 2016 Aug 17. ID - ref263 ER - TY - JOUR AU - Bonkhoff, H. AU - Berges, R. PY - 2009 DA - 2009// TI - The evolving role of oestrogens and their receptors in the development and progression of prostate cancer JO - Eur Urol. VL - 55 UR - https://doi.org/10.1016/j.eururo.2008.10.035 DO - 10.1016/j.eururo.2008.10.035 ID - Bonkhoff2009 ER - TY - JOUR AU - Connors, J. M. AU - Levy, J. H. PY - 2020 DA - 2020// TI - COVID-19 and its implications for thrombosis and anticoagulation JO - Blood. VL - 135 UR - https://doi.org/10.1182/blood.2020006000 DO - 10.1182/blood.2020006000 ID - Connors2020 ER - TY - JOUR AU - Haematology, T. L. PY - 2020 DA - 2020// TI - COVID-19 coagulopathy: an evolving story JO - Lancet Haematol. VL - 7 UR - https://doi.org/10.1016/S2352-3026(20)30151-4 DO - 10.1016/S2352-3026(20)30151-4 ID - Haematology2020 ER - TY - JOUR AU - Becker, R. C. PY - 2020 DA - 2020// TI - COVID-19 update: Covid-19-associated coagulopathy JO - J Thromb Thrombolysis. VL - 50 UR - https://doi.org/10.1007/s11239-020-02134-3 DO - 10.1007/s11239-020-02134-3 ID - Becker2020 ER - TY - JOUR AU - Scheres, L. J. J. AU - Hylckama Vlieg, A. AU - Ballieux, B. E. P. B. PY - 2019 DA - 2019// TI - Endogenous sex hormones and risk of venous thromboembolism in young women JO - J Thromb Haemost. VL - 17 UR - https://doi.org/10.1111/jth.14474 DO - 10.1111/jth.14474 ID - Scheres2019 ER - TY - JOUR AU - Laliberté, F. AU - Dea, K. AU - Duh, M. S. AU - Kahler, K. H. AU - Rolli, M. AU - Lefebvre, P. PY - 2018 DA - 2018// TI - Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy JO - Menopause. VL - 25 UR - https://doi.org/10.1097/GME.0000000000001232 DO - 10.1097/GME.0000000000001232 ID - Laliberté2018 ER - TY - JOUR AU - Simon, J. A. AU - Laliberté, F. AU - Duh, M. S. PY - 2016 DA - 2016// TI - Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy JO - Menopause. VL - 23 UR - https://doi.org/10.1097/GME.0000000000000590 DO - 10.1097/GME.0000000000000590 ID - Simon2016 ER - TY - JOUR AU - Rovinski, D. AU - Ramos, R. B. AU - Fighera, T. M. AU - Casanova, G. K. AU - Spritzer, P. M. PY - 2018 DA - 2018// TI - Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis JO - Thromb Res. VL - 168 UR - https://doi.org/10.1016/j.thromres.2018.06.014 DO - 10.1016/j.thromres.2018.06.014 ID - Rovinski2018 ER - TY - STD TI - Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? [published online ahead of print, 2020 May 29]. J Clin Hypertens (Greenwich). 2020;https://doi.org/10.1111/jch.13912. ID - ref272 ER - TY - STD TI - Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study [published online ahead of print, 2020 May 29]. Diabetologia. 2020;1-16. ID - ref273 ER - TY - STD TI - Scheen AJ, Marre M, Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports [published online ahead of print, 2020 May 21]. Diabetes Metab. 2020;S1262-3636(20)30085-9. ID - ref274 ER - TY - STD TI - Wang YW, He SJ, Feng X, et al. Metformin: a review of its potential indications. Drug Des Devel Ther. 2017;11:2421-2429. Published 2017 Aug 22. ID - ref275 ER - TY - STD TI - Shurrab NT, Arafa EA. Metformin: A review of its therapeutic efficacy and adverse effects. Obes Med. 2020;17:100186. ID - ref276 ER - TY - STD TI - Siang KC, Hasan SS. Metformin use amid COVID-19 pandemic [published online ahead of print, 2020 May 29]. J Med Virol. 2020;https://doi.org/10.1002/jmv.26090. ID - ref277 ER - TY - STD TI - El-Arabey AA, Abdalla M. Metformin and COVID-19: A novel deal of an Old Drug [published online ahead of print, 2020 Apr 29]. J Med Virol. 2020;https://doi.org/10.1002/jmv.25958. ID - ref278 ER - TY - STD TI - Menendez JA. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19 [published online ahead of print, 2020 May 27]. Aging (Albany NY). 2020;12:https://doi.org/10.18632/aging.103347. ID - ref279 ER - TY - STD TI - Luo P, Qiu L, Liu Y, et al. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis [published online ahead of print, 2020 May 21]. Am J Trop Med Hyg. 2020;https://doi.org/10.4269/ajtmh.20-0375. ID - ref280 ER - TY - STD TI - Dalan R. Metformin, Neutrophils and COVID-19 Infection [published online ahead of print, 2020 May 21]. Diabetes Res Clin Pract. 2020;108230. ID - ref281 ER - TY - STD TI - Penlioglou T, Papachristou S, Papanas N. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone? [published online ahead of print, 2020 May 7]. Diabetes Ther. 2020;1-3. ID - ref282 ER - TY - JOUR AU - Sharma, S. AU - Ray, A. AU - Sadasivam, B. PY - 2020 DA - 2020// TI - Metformin in COVID-19: A possible role beyond diabetes [published online ahead of print, 2020 Apr 30] JO - Diabetes Res Clin Pract. VL - 164 UR - https://doi.org/10.1016/j.diabres.2020.108183 DO - 10.1016/j.diabres.2020.108183 ID - Sharma2020 ER - TY - JOUR AU - Tsaknis, G. AU - Siempos, I. I. AU - Kopterides, P. PY - 2012 DA - 2012// TI - Metformin attenuates ventilator-induced lung injury JO - Crit Care. VL - 16 UR - https://doi.org/10.1186/cc11439 DO - 10.1186/cc11439 ID - Tsaknis2012 ER - TY - JOUR AU - Vaez, H. AU - Najafi, M. AU - Toutounchi, N. S. AU - Barar, J. AU - Barzegari, A. AU - Garjani, A. PY - 2016 DA - 2016// TI - Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling JO - Iran J Allergy Asthma Immunol. VL - 15 ID - Vaez2016 ER - TY - JOUR AU - Jian, M. Y. AU - Alexeyev, M. F. AU - Wolkowicz, P. E. AU - Zmijewski, J. W. AU - Creighton, J. R. PY - 2013 DA - 2013// TI - Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury JO - Am J Physiol Lung Cell Mol Physiol. VL - 305 UR - https://doi.org/10.1152/ajplung.00173.2013 DO - 10.1152/ajplung.00173.2013 ID - Jian2013 ER - TY - JOUR AU - Zhang, X. AU - Shang, F. AU - Hui, L. AU - Zang, K. AU - Sun, G. PY - 2017 DA - 2017// TI - The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism JO - Saudi Pharm J. VL - 25 UR - https://doi.org/10.1016/j.jsps.2017.05.001 DO - 10.1016/j.jsps.2017.05.001 ID - Zhang2017 ER - TY - JOUR AU - Yu, L. L. AU - Zhu, M. AU - Huang, Y. PY - 2018 DA - 2018// TI - Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression JO - Eur Rev Med Pharmacol Sci. VL - 22 ID - Yu2018 ER - TY - JOUR AU - Ghavimi, H. AU - Sheidaei, S. AU - Vaez, H. AU - Zolali, E. AU - Asgharian, P. AU - Hamishehkar, H. PY - 2018 DA - 2018// TI - Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin JO - Iran J Basic Med Sci. VL - 21 ID - Ghavimi2018 ER - TY - STD TI - Tsai WL, Chang TH, Sun WC, et al. Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase. Oncotarget. 2017;8(54):91928-91937. Published 2017 Aug 14. ID - ref290 ER - TY - JOUR AU - Xun, Y. H. AU - Zhang, Y. J. AU - Pan, Q. C. PY - 2014 DA - 2014// TI - Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells JO - J Viral Hepat. VL - 21 UR - https://doi.org/10.1111/jvh.12187 DO - 10.1111/jvh.12187 ID - Xun2014 ER - TY - JOUR AU - Xiao, Y. AU - Liu, F. AU - Li, S. PY - 2020 DA - 2020// TI - Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway JO - Virulence. VL - 11 UR - https://doi.org/10.1080/21505594.2019.1706305 DO - 10.1080/21505594.2019.1706305 ID - Xiao2020 ER - TY - JOUR AU - Chen, Y. AU - Gu, F. AU - Guan, J. L. PY - 2018 DA - 2018// TI - Metformin Might Inhibit Virus through Increasing Insulin Sensitivity JO - Chin Med J (Engl). VL - 131 UR - https://doi.org/10.4103/0366-6999.223856 DO - 10.4103/0366-6999.223856 ID - Chen2018 ER - TY - JOUR AU - Diaz, A. AU - Romero, M. AU - Vazquez, T. AU - Lechner, S. AU - Blomberg, B. B. AU - Frasca, D. PY - 2017 DA - 2017// TI - Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes JO - Vaccine. VL - 35 UR - https://doi.org/10.1016/j.vaccine.2017.03.078 DO - 10.1016/j.vaccine.2017.03.078 ID - Diaz2017 ER - TY - JOUR AU - Lalau, J. D. AU - Kajbaf, F. AU - Protti, A. AU - Christensen, M. M. AU - Broe, M. E. AU - Wiernsperger, N. PY - 2017 DA - 2017// TI - Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm JO - Diabetes Obes Metab. VL - 19 UR - https://doi.org/10.1111/dom.12974 DO - 10.1111/dom.12974 ID - Lalau2017 ER - TY - STD TI - Shin SJ, Chung S, Kim SJ, et al. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes. PLoS One. 2016;11(11):e0165703. Published 2016 Nov 1. ID - ref296 ER - TY - STD TI - Bonora BM, Avogaro A, Fadini GP. Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence. Diabetes Metab Syndr Obes. 2020;13:161-174. Published 2020 Jan 21. ID - ref297 ER - TY - STD TI - Kuchay MS, Farooqui KJ, Mishra SK, Mithal A. Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors [published online ahead of print, 2020 Feb 1]. Adv Exp Med Biol. 2020;https://doi.org/10.1007/5584_2020_479. ID - ref298 ER - TY - JOUR AU - Li, L. AU - Konishi, Y. AU - Morikawa, T. PY - 2018 DA - 2018// TI - et al. Effect of a SGLT2 inhibitor on the systemic and intrarenal renin-angiotensin system in subtotally nephrectomized rats JO - J Pharmacol Sci VL - 137 UR - https://doi.org/10.1016/j.jphs.2017.10.006 DO - 10.1016/j.jphs.2017.10.006 ID - Li2018 ER - TY - STD TI - Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N. SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects. Int J Environ Res Public Health. 2019;16(16):2965. Published 2019 Aug 17. doi:https://doi.org/10.3390/ijerph16162965. ID - ref300 ER - TY - STD TI - Petrykiv S, Laverman GD, de Zeeuw D, Heerspink HJL. Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?. Diabetes Obes Metab. 2018;20(1):224-227. ID - ref301 ER - TY - STD TI - Schork A, Saynisch J, Vosseler A, et al. Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy. Cardiovasc Diabetol. 2019;18(1):46. Published 2019 Apr 5. ID - ref302 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04393246 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04393246 ID - ref303 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04350593 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04350593 ID - ref304 ER - TY - STD TI - Cure E, Cumhur Cure M. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis [published online ahead of print, 2020 Apr 21]. Diabetes Metab Syndr. 2020;14(4):405-406. ID - ref305 ER - TY - STD TI - Mirabelli M, Chiefari E, Puccio L, Foti DP, Brunetti A. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis. Int J Environ Res Public Health. 2020;17(10):E3664. Published 2020 May 22. ID - ref306 ER - TY - STD TI - Zhu T, Li C, Zhang X, et al. GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway. Mediators Inflamm. 2018;2018:3601454. Published 2018 May 22. ID - ref307 ER - TY - JOUR AU - Xu, J. AU - Wei, G. AU - Wang, J. PY - 2019 DA - 2019// TI - Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function JO - Lab Invest. VL - 99 UR - https://doi.org/10.1038/s41374-018-0170-0 DO - 10.1038/s41374-018-0170-0 ID - Xu2019 ER - TY - JOUR AU - Zhou, F. AU - Zhang, Y. AU - Chen, J. AU - Hu, X. AU - Xu, Y. PY - 2016 DA - 2016// TI - Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice JO - Eur J Pharmacol. VL - 791 UR - https://doi.org/10.1016/j.ejphar.2016.10.016 DO - 10.1016/j.ejphar.2016.10.016 ID - Zhou2016 ER - TY - STD TI - Rowlands J, Heng J, Newsholme P, Carlessi R. Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function. Front Endocrinol (Lausanne). 2018;9:672. Published 2018 Nov 23. ID - ref310 ER - TY - STD TI - Muskiet MHA, Wheeler DC, Heerspink HJL. New pharmacological strategies for protecting kidney function in type 2 diabetes [published correction appears in Lancet Diabetes Endocrinol. 2019 Feb 4;:]. Lancet Diabetes Endocrinol. 2019;7(5):397-412. ID - ref311 ER - TY - JOUR AU - Jiménez, D. L. AU - Babkowski, M. C. AU - Miramontes González, J. P. PY - 2019 DA - 2019// TI - GLP-1 and the renin-angiotensin-aldosterone system JO - Lancet Diabetes Endocrinol. VL - 7 UR - https://doi.org/10.1016/S2213-8587(19)30065-8 DO - 10.1016/S2213-8587(19)30065-8 ID - Jiménez2019 ER - TY - JOUR AU - Skov, J. AU - Pedersen, M. AU - Holst, J. J. PY - 2016 DA - 2016// TI - Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial JO - Diabetes Obes Metab. VL - 18 UR - https://doi.org/10.1111/dom.12651 DO - 10.1111/dom.12651 ID - Skov2016 ER - TY - JOUR AU - Skov, J. AU - Persson, F. AU - Frøkiær, J. AU - Christiansen, J. S. PY - 2014 DA - 2014// TI - Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease JO - Front Endocrinol (Lausanne). VL - 5 UR - https://doi.org/10.3389/fendo.2014.00023 DO - 10.3389/fendo.2014.00023 ID - Skov2014 ER - TY - JOUR AU - Skov, J. AU - Dejgaard, A. AU - Frøkiær, J. PY - 2013 DA - 2013// TI - Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men JO - J Clin Endocrinol Metab. VL - 98 UR - https://doi.org/10.1210/jc.2012-3855 DO - 10.1210/jc.2012-3855 ID - Skov2013 ER - TY - STD TI - Li Y, Zhang Z, Yang L, et al. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike [published online ahead of print, 2020 May 13]. iScience. 2020;23(6):101160. ID - ref316 ER - TY - STD TI - Fadini GP, Morieri ML, Longato E, et al. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study [published online ahead of print, 2020 May 28]. Diabetes Obes Metab. 2020;https://doi.org/10.1111/dom.14097. ID - ref317 ER - TY - STD TI - Dalan R. Is DPP4 inhibition a comrade or adversary in COVID-19 infection [published online ahead of print, 2020 May 19]. Diabetes Res Clin Pract. 2020;164:108216. ID - ref318 ER - TY - JOUR AU - Strollo, R. AU - Pozzilli, P. PY - 2020 DA - 2020// TI - DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? [published online ahead of print, 2020 Apr 26] JO - Diabetes Metab Res Rev UR - https://doi.org/10.1002/dmrr.3330 DO - 10.1002/dmrr.3330 ID - Strollo2020 ER - TY - STD TI - Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? [published online ahead of print, 2020 May 11]. J Diabetes. 2020; https://doi.org/10.1111/1753–0407.13052. UR - https://doi.org/10.1111/1753–0407.13052 ID - ref320 ER - TY - JOUR AU - Kawasaki, T. AU - Chen, W. AU - Htwe, Y. M. AU - Tatsumi, K. AU - Dudek, S. M. PY - 2018 DA - 2018// TI - DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice JO - Am J Physiol Lung Cell Mol Physiol. VL - 315 UR - https://doi.org/10.1152/ajplung.00031.2018 DO - 10.1152/ajplung.00031.2018 ID - Kawasaki2018 ER - TY - STD TI - Suzuki T, Tada Y, Gladson S, et al. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res. 2017;18(1):177. Published 2017 Oct 16. ID - ref322 ER - TY - JOUR AU - Beckers, P. A. J. AU - Gielis, J. F. AU - Schil, P. E. AU - Adriaensen, D. PY - 2017 DA - 2017// TI - Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition JO - Ann Transl Med. VL - 5 UR - https://doi.org/10.21037/atm.2017.01.41 DO - 10.21037/atm.2017.01.41 ID - Beckers2017 ER - TY - STD TI - Guo K, Jin F. Dipeptidyl peptidase-4 (DPP-4) inhibitor saxagliptin alleviates lipopolysaccharide-induced acute lung injury via regulating the Nrf-2/HO-1 and NF-κB pathways [published online ahead of print, 2019 Nov 7]. J Invest Surg. 2019;1-8. ID - ref324 ER - TY - JOUR AU - Letko, M. AU - Miazgowicz, K. AU - McMinn, R. PY - 2018 DA - 2018// TI - Adaptive Evolution of MERS-CoV to Species Variation in DPP4 JO - Cell Rep. VL - 24 UR - https://doi.org/10.1016/j.celrep.2018.07.045 DO - 10.1016/j.celrep.2018.07.045 ID - Letko2018 ER - TY - JOUR AU - Wang, N. AU - Shi, X. AU - Jiang, L. PY - 2013 DA - 2013// TI - Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 JO - Cell Res. VL - 23 UR - https://doi.org/10.1038/cr.2013.92 DO - 10.1038/cr.2013.92 ID - Wang2013 ER - TY - JOUR AU - Peck, K. M. AU - Scobey, T. AU - Swanstrom, J. PY - 2017 DA - 2017// TI - Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants JO - J Virol. VL - 91 UR - https://doi.org/10.1128/JVI.00534-17 DO - 10.1128/JVI.00534-17 ID - Peck2017 ER - TY - JOUR AU - Dastan, F. AU - Abedini, A. AU - Shahabi, S. AU - Kiani, A. AU - Saffaei, A. AU - Zare, A. PY - 2020 DA - 2020// TI - Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung JO - Iran J Allergy Asthma Immunol. VL - 19 ID - Dastan2020 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04382794 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04382794 ID - ref329 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04365517 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04365517 ID - ref330 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04341935 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04341935 ID - ref331 ER - TY - STD TI - Carboni E, Carta AR, Carboni E. Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? [published online ahead of print, 2020 Apr 22]. Med Hypotheses. 2020;140:109776. ID - ref332 ER - TY - STD TI - Kvandova M, Barancik M, Balis P, Puzserova A, Majzunova M, Dovinova I. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats. J Physiol Pharmacol. 2018;69(2):https://doi.org/10.26402/jpp.2018.2.09. ID - ref333 ER - TY - JOUR AU - Zhang, W. AU - Li, C. AU - Liu, B. PY - 2013 DA - 2013// TI - Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis JO - Ann Hepatol. VL - 12 UR - https://doi.org/10.1016/S1665-2681(19)31294-3 DO - 10.1016/S1665-2681(19)31294-3 ID - Zhang2013 ER - TY - STD TI - Zhang W, Xu YZ, Liu B, et al. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. ScientificWorldJournal. 2014;2014:603409. Published 2014 Jan 14. ID - ref335 ER - TY - JOUR AU - Kurisu, S. AU - Iwasaki, T. AU - Ishibashi, K. PY - 2013 DA - 2013// TI - Effects of low-dose pioglitazone on glucose control, lipid profiles, renin-angiotensin-aldosterone system and natriuretic peptides in diabetic patients with coronary artery disease JO - J Renin Angiotensin Aldosterone Syst. VL - 14 UR - https://doi.org/10.1177/1470320312452028 DO - 10.1177/1470320312452028 ID - Kurisu2013 ER - TY - JOUR AU - Kutsukake, M. AU - Matsutani, T. AU - Tamura, K. PY - 2014 DA - 2014// TI - Pioglitazone attenuates lung injury by modulating adipose inflammation JO - J Surg Res. VL - 189 UR - https://doi.org/10.1016/j.jss.2014.03.007 DO - 10.1016/j.jss.2014.03.007 ID - Kutsukake2014 ER - TY - JOUR AU - Matsutani, T. AU - Tamura, K. AU - Kutsukake, M. AU - Matsuda, A. AU - Tachikawa, E. AU - Uchida, E. PY - 2017 DA - 2017// TI - Impact of Pioglitazone on Macrophage Dynamics in Adipose Tissues of Cecal Ligation and Puncture-Treated Mice JO - Biol Pharm Bull. VL - 40 UR - https://doi.org/10.1248/bpb.b16-00883 DO - 10.1248/bpb.b16-00883 ID - Matsutani2017 ER - TY - JOUR AU - Grommes, J. AU - Mörgelin, M. AU - Soehnlein, O. PY - 2012 DA - 2012// TI - Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment JO - Eur Respir J. VL - 40 UR - https://doi.org/10.1183/09031936.00091011 DO - 10.1183/09031936.00091011 ID - Grommes2012 ER - TY - JOUR AU - Kaplan, J. AU - Nowell, M. AU - Chima, R. AU - Zingarelli, B. PY - 2014 DA - 2014// TI - Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis JO - Innate Immun. VL - 20 UR - https://doi.org/10.1177/1753425913501565 DO - 10.1177/1753425913501565 ID - Kaplan2014 ER - TY - JOUR AU - Ciavarella, C. AU - Motta, I. AU - Valente, S. AU - Pasquinelli, G. PY - 2020 DA - 2020// TI - Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease JO - Molecules. VL - 25 UR - https://doi.org/10.3390/molecules25092076 DO - 10.3390/molecules25092076 ID - Ciavarella2020 ER - TY - JOUR AU - Chojkier, M. AU - Elkhayat, H. AU - Sabry, D. AU - Donohue, M. AU - Buck, M. PY - 2012 DA - 2012// TI - Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study JO - PLoS One. VL - 7 UR - https://doi.org/10.1371/journal.pone.0031516 DO - 10.1371/journal.pone.0031516 ID - Chojkier2012 ER - TY - STD TI - Fukano K, Tsukuda S, Oshima M, et al. Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes. Front Microbiol. 2019;9:3257. Published 2019 Jan 8. ID - ref343 ER - TY - STD TI - Khattab M, Emad M, Abdelaleem A, et al. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. Liver Int. 2010;30(3):447-454. ID - ref344 ER - TY - STD TI - Guerrero CA, Murillo A, Acosta O. Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARγ agonists and NSAIDs [published correction appears in Antiviral Res. 2012 Nov;96(2):269. Guererero, Carlos A [corrected to Guerrero, Carlos A]]. Antiviral Res. 2012;96(1):1-12. ID - ref345 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04473274 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04473274 ID - ref346 ER - TY - JOUR AU - Morath, C. AU - Ratzlaff, K. AU - Dechow, C. PY - 2009 DA - 2009// TI - Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats JO - J Mol Med (Berl). VL - 87 UR - https://doi.org/10.1007/s00109-008-0404-5 DO - 10.1007/s00109-008-0404-5 ID - Morath2009 ER - TY - STD TI - Abdelmaksoud A, Vestita M, El-Amawy HS, et al. Systemic isotretinoin therapy in the era of COVID-19 [published online ahead of print, 2020 May 1]. Dermatol Ther. 2020:e13482. https://doi.org/10.1111/dth.13482. ID - ref348 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04361422 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04361422 ID - ref349 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04353180 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04353180 ID - ref350 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04389580 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04389580 ID - ref351 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04396067 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04396067 ID - ref352 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04382950 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04382950 ID - ref353 ER - TY - JOUR AU - Vemuri, V. K. AU - Janero, D. R. AU - Makriyannis, A. PY - 2008 DA - 2008// TI - Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome JO - Physiol Behav. VL - 93 UR - https://doi.org/10.1016/j.physbeh.2007.11.012 DO - 10.1016/j.physbeh.2007.11.012 ID - Vemuri2008 ER - TY - JOUR AU - Xie, S. AU - Furjanic, M. A. AU - Ferrara, J. J. PY - 2007 DA - 2007// TI - The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use JO - J Clin Pharm Ther. VL - 32 UR - https://doi.org/10.1111/j.1365-2710.2007.00817.x DO - 10.1111/j.1365-2710.2007.00817.x ID - Xie2007 ER - TY - JOUR AU - Topol, E. J. AU - Bousser, M. G. AU - Fox, K. A. PY - 2010 DA - 2010// TI - Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60935-X DO - 10.1016/S0140-6736(10)60935-X ID - Topol2010 ER - TY - STD TI - Ludtke DD, Siteneski A, de Oliveira Galassi T, et al. High-intensity swimming exercise reduces inflammatory pain in mice by activation of the endocannabinoid system [published online ahead of print, 2020 May 1]. Scand J Med Sci Sports. ID - ref357 ER - TY - JOUR AU - Kaser, S. AU - Ebenbichler, C. F. AU - Tilg, H. PY - 2010 DA - 2010// TI - Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease JO - Int J Clin Pract. VL - 64 UR - https://doi.org/10.1111/j.1742-1241.2009.02327.x DO - 10.1111/j.1742-1241.2009.02327.x ID - Kaser2010 ER - TY - JOUR AU - Schaich, C. L. AU - Shaltout, H. A. AU - Brosnihan, K. B. AU - Howlett, A. C. AU - Diz, D. I. PY - 2014 DA - 2014// TI - Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats JO - Physiol Rep. VL - 2 UR - https://doi.org/10.14814/phy2.12108 DO - 10.14814/phy2.12108 ID - Schaich2014 ER - TY - STD TI - Ciaglia E, Vecchione C, Puca AA. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children. Front Pediatr. 2020;8:206. Published 2020 Apr 23. ID - ref360 ER - TY - JOUR AU - Mestre, L. AU - Carrillo-Salinas, F. J. AU - Mecha, M. AU - Feliú, A. AU - Guaza, C. PY - 2018 DA - 2018// TI - Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis JO - Biochem Pharmacol. VL - 157 UR - https://doi.org/10.1016/j.bcp.2018.08.037 DO - 10.1016/j.bcp.2018.08.037 ID - Mestre2018 ER - TY - STD TI - Angelina A, Pérez-Diego M, López-Abente J, Palomares O. The Role of Cannabinoids in Allergic Diseases [published online ahead of print, 2020 Jun 11]. Int Arch Allergy Immunol. 2020:1–20. ID - ref362 ER - TY - JOUR AU - Rieder, S. A. AU - Chauhan, A. AU - Singh, U. AU - Nagarkatti, M. AU - Nagarkatti, P. PY - 2010 DA - 2010// TI - Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression JO - Immunobiology. VL - 215 UR - https://doi.org/10.1016/j.imbio.2009.04.001 DO - 10.1016/j.imbio.2009.04.001 ID - Rieder2010 ER - TY - STD TI - Briand-Mésange F, Trudel S, Salles J, Ausseil J, Salles JP, Chap H. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return? [published online ahead of print, 2020 May 28]. Obesity (Silver Spring). 2020;10.1002/oby.22916. ID - ref364 ER - TY - STD TI - Rossi F, Tortora C, Argenziano M, Di Paola A, Punzo F. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?. Int J Mol Sci. 2020;21(11):E3809. Published 2020 May 27. ID - ref365 ER - TY - JOUR AU - Huang, S. A. AU - Lie, J. D. PY - 2013 DA - 2013// TI - Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction JO - P T. VL - 38 ID - Huang2013 ER - TY - STD TI - Wang G, Zhang Q, Yuan W, Wu J, Li C. Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System. Int J Mol Sci. 2015;16(11):27015-27031. Published 2015 Nov 12. ID - ref367 ER - TY - STD TI - Kosutova P, Mikolka P, Balentova S, et al. Effects of phosphodiesterase 5 inhibitor sildenafil on the respiratory parameters, inflammation and apoptosis in a saline lavage-induced model of acute lung injury. J Physiol Pharmacol. 2018;69(5):https://doi.org/10.26402/jpp.2018.5.15. ID - ref368 ER - TY - JOUR AU - Guerra-Mora, J. R. AU - Perales-Caldera, E. AU - Aguilar-León, D. PY - 2017 DA - 2017// TI - Effects of Sildenafil and Tadalafil on Edema and Reactive Oxygen Species Production in an Experimental Model of Lung Ischemia-Reperfusion Injury JO - Transplant Proc. VL - 49 UR - https://doi.org/10.1016/j.transproceed.2017.03.089 DO - 10.1016/j.transproceed.2017.03.089 ID - Guerra-Mora2017 ER - TY - JOUR AU - Gokakin, A. K. AU - Deveci, K. AU - Kurt, A. PY - 2013 DA - 2013// TI - The protective effects of sildenafil in acute lung injury in a rat model of severe scald burn: A biochemical and histopathological study JO - Burns. VL - 39 UR - https://doi.org/10.1016/j.burns.2012.12.017 DO - 10.1016/j.burns.2012.12.017 ID - Gokakin2013 ER - TY - STD TI - Kniotek M, Boguska A. Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients. J Immunol Res. 2017;2017:4541958. ID - ref371 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04304313 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04304313 ID - ref372 ER - TY - JOUR AU - Morgante, G. AU - Delia, A. AU - Musacchio, M. C. AU - Severi, F. M. AU - Petraglia, F. AU - Leo, V. PY - 2006 DA - 2006// TI - Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women JO - Gynecol Endocrinol. VL - 22 UR - https://doi.org/10.1080/09513590600850300 DO - 10.1080/09513590600850300 ID - Morgante2006 ER - TY - JOUR AU - Sumino, H. AU - Ichikawa, S. AU - Kasama, S. PY - 2010 DA - 2010// TI - Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women JO - Geriatr Gerontol Int. VL - 10 UR - https://doi.org/10.1111/j.1447-0594.2009.00562.x DO - 10.1111/j.1447-0594.2009.00562.x ID - Sumino2010 ER - TY - JOUR AU - Zhou, G. J. AU - Zhang, H. AU - Zhi, S. D. PY - 2007 DA - 2007// TI - Protective effect of raloxifene on lipopolysaccharide and acid- induced acute lung injury in rats JO - Acta Pharmacol Sin. VL - 28 UR - https://doi.org/10.1111/j.1745-7254.2007.00637.x DO - 10.1111/j.1745-7254.2007.00637.x ID - Zhou2007 ER - TY - STD TI - Ellis AJ, Hendrick VM, Williams R, Komm BS. Selective estrogen receptor modulators in clinical practice: a safety overview [published correction appears in Expert Opin Drug Saf. 2015;14(11):1799-1800]. ID - ref376 ER - TY - JOUR AU - Boyack, M. AU - Lookinland, S. AU - Chasson, S. PY - 2002 DA - 2002// TI - Efficacy of raloxifene for treatment of menopause: a systematic review JO - J Am Acad Nurse Pract. VL - 14 UR - https://doi.org/10.1111/j.1745-7599.2002.tb00107.x DO - 10.1111/j.1745-7599.2002.tb00107.x ID - Boyack2002 ER - TY - JOUR AU - Shekarforoush, S. AU - Koohpeyma, F. AU - Safari, F. PY - 2019 DA - 2019// TI - Alteration at transcriptional level of cardiac renin-angiotensin system by letrozole treatment JO - Acta Cardiol. VL - 74 UR - https://doi.org/10.1080/00015385.2018.1472840 DO - 10.1080/00015385.2018.1472840 ID - Shekarforoush2019 ER - TY - JOUR AU - Chanplakorn, N. AU - Chanplakorn, P. AU - Suzuki, T. PY - 2011 DA - 2011// TI - Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation JO - Horm Cancer. VL - 2 UR - https://doi.org/10.1007/s12672-010-0062-2 DO - 10.1007/s12672-010-0062-2 ID - Chanplakorn2011 ER - TY - STD TI - Takagi K, Miki Y, Nagasaki S, et al. Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment. Endocr Relat Cancer. 2010;17(2):415-430. Published 2010 Apr 21. ID - ref380 ER - TY - JOUR AU - Hierweger, A. M. AU - Engler, J. B. AU - Friese, M. A. PY - 2019 DA - 2019// TI - Progesterone modulates the T-cell response via glucocorticoid receptor-dependent pathways JO - Am J Reprod Immunol. VL - 81 UR - https://doi.org/10.1111/aji.13084 DO - 10.1111/aji.13084 ID - Hierweger2019 ER - TY - JOUR AU - Oelkers, W. PY - 2002 DA - 2002// TI - The renin-aldosterone system and drospirenone JO - Gynecol Endocrinol. VL - 16 ID - Oelkers2002 ER - TY - JOUR AU - Keller-Wood, M. AU - Silbiger, J. AU - Wood, C. E. PY - 1990 DA - 1990// TI - Progesterone-cortisol interaction in control of renin activity but not aldosterone JO - Am J Physiol. VL - 259 ID - Keller-Wood1990 ER - TY - STD TI - Rogosnitzky M, Berkowitz E, Jadad AR. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point. JMIR Public Health Surveill. 2020;6(2):e19199. Published 2020 May 13. ID - ref384 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04365127 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04365127 ID - ref385 ER - TY - STD TI - Jean SS, Hsueh PR. Old and re-purposed drugs for the treatment of COVID-19 [published online ahead of print, 2020 Jun 1]. Expert Rev Anti Infect Ther. 2020;1-5. ID - ref386 ER - TY - STD TI - https://clinicaltrials.gov/ct2/show/NCT04356417 (Last accessed: July 23rd, 2020). UR - https://clinicaltrials.gov/ct2/show/NCT04356417 ID - ref387 ER -